Imiquimod Cream
Product Images NDC 71335-2725

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 71335-2725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Figure 1)

This text appears to be describing a study or trial involving Imiquimod Cream Vehide. There were a total of 109 participants, with 100 completing 16 weeks of treatment while some withdrew. The text also mentions results after 12 weeks of follow-up, with some participants remaining clear. The study seems to be evaluating the effectiveness or outcomes of Imiquimod Cream Vehide.*

FDA Label Image

Image 11 (Image 01)

FDA Label Image

Label (Lbl713352725)

Each 0.25g single-use packet of this product contains Imiquimod 12.5mg along with various inactive ingredients. It is recommended for dermatologic use only and not for ophthalmic use, specifying instructions for proper storage. The packaging is not child-resistant and should be kept out of reach of children.联系。*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.